Lung Cancer Therapy Research Report 2024: Demand for Targeted Therapy, Arrival of Nanomedicine, Emergence of New Diagnostics and Advanced Therapies, Growth of Combination Therapy - Forecas...
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Therapy Type, By Indication, By End-User, By Region Size and Trends and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. The global lung cancer therapy market was valued at US$32.50 billion in 2023. The market value is expected to reach US$70.39 billion by 2029. The market is expected to grow at a CAGR of approx. 14% during the forecasted period of 2024-2029. Lung cancer therapy is a critical area of oncology, focusing on the treatment of lung cancer, one of the most prevalent and deadly forms of cancer worldwide. Traditionally, lung cancer treatment relied heavily on chemotherapy and radiation therapy. However, recent years have seen a surge in the development and adoption of targeted therapies and immunotherapies, which have revolutionized the approach to treatment. Looking ahead, the global lung cancer therapy market is expected to continue its growth trajectory. The ongoing research and development of new therapies, including the exploration o
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- New Alzheimer's prevention trial receives $74.5 million NIH grant [Yahoo! Finance]Yahoo! Finance
- 2 Top Growth Stocks to Buy on the Dip [Yahoo! Finance]Yahoo! Finance
- 3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years [Yahoo! Finance]Yahoo! Finance
- Lilly expands R&D footprint in Singapore with SGD$42 million investment in new Digital Health Innovation Hub [Yahoo! Finance]Yahoo! Finance
- Treatment with tirzepatide in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss and nearly 99% remained diabetes-free at 176 weeks [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 10/30/24 - Miss
LLY
Sec Filings
- 11/8/24 - Form 144
- 11/8/24 - Form 4
- 11/5/24 - Form 4
- LLY's page on the SEC website